[(2S,3R,4S,5S,6R)-4,5-dihydroxy-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-6-[[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl] (4aS,6aR,6aS,6bR,8aR,10S,12aR,14bS)-10-[(2R,3R,4S,5R,6R)-4,5-dihydroxy-6-methyl-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylate

Details

Top
Internal ID a0960f7e-06f7-402a-b905-89d43c1f16aa
Taxonomy Lipids and lipid-like molecules > Prenol lipids > Terpene glycosides > Triterpene glycosides > Triterpene saponins
IUPAC Name [(2S,3R,4S,5S,6R)-4,5-dihydroxy-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-6-[[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl] (4aS,6aR,6aS,6bR,8aR,10S,12aR,14bS)-10-[(2R,3R,4S,5R,6R)-4,5-dihydroxy-6-methyl-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylate
SMILES (Canonical)
SMILES (Isomeric)
InChI InChI=1S/C60H98O24/c1-24-34(61)39(66)44(71)49(76-24)75-23-30-38(65)43(70)48(83-51-46(73)41(68)36(63)26(3)78-51)53(80-30)84-54(74)60-20-18-55(5,6)22-29(60)28-12-13-32-57(9)16-15-33(56(7,8)31(57)14-17-59(32,11)58(28,10)19-21-60)81-52-47(42(69)37(64)27(4)79-52)82-50-45(72)40(67)35(62)25(2)77-50/h12,24-27,29-53,61-73H,13-23H2,1-11H3/t24-,25+,26+,27-,29+,30-,31+,32-,33+,34+,35+,36+,37+,38-,39+,40-,41-,42+,43+,44-,45-,46-,47-,48-,49-,50+,51+,52+,53+,57+,58-,59-,60+/m1/s1
InChI Key UYTPORHNVQVGRX-PXUAPPAUSA-N
Popularity 2 references in papers

Physical and Chemical Properties

Top
Molecular Formula C60H98O24
Molecular Weight 1203.40 g/mol
Exact Mass 1202.64480399 g/mol
Topological Polar Surface Area (TPSA) 372.00 Ų
XlogP 0.80
Atomic LogP (AlogP) -0.10
H-Bond Acceptor 24
H-Bond Donor 13
Rotatable Bonds 11

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of [(2S,3R,4S,5S,6R)-4,5-dihydroxy-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-6-[[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl] (4aS,6aR,6aS,6bR,8aR,10S,12aR,14bS)-10-[(2R,3R,4S,5R,6R)-4,5-dihydroxy-6-methyl-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylate

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.8557 85.57%
Caco-2 - 0.8768 87.68%
Blood Brain Barrier - 0.7250 72.50%
Human oral bioavailability - 0.7000 70.00%
Subcellular localzation Mitochondria 0.8875 88.75%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.8029 80.29%
OATP1B3 inhibitior - 0.4647 46.47%
MATE1 inhibitior - 0.9000 90.00%
OCT2 inhibitior - 0.5776 57.76%
BSEP inhibitior + 0.9081 90.81%
P-glycoprotein inhibitior + 0.7471 74.71%
P-glycoprotein substrate - 0.7539 75.39%
CYP3A4 substrate + 0.7228 72.28%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.8572 85.72%
CYP3A4 inhibition - 0.9472 94.72%
CYP2C9 inhibition - 0.8457 84.57%
CYP2C19 inhibition - 0.8975 89.75%
CYP2D6 inhibition - 0.9373 93.73%
CYP1A2 inhibition - 0.8290 82.90%
CYP2C8 inhibition + 0.6790 67.90%
CYP inhibitory promiscuity - 0.9112 91.12%
UGT catelyzed + 0.6000 60.00%
Carcinogenicity (binary) - 0.9700 97.00%
Carcinogenicity (trinary) Non-required 0.6525 65.25%
Eye corrosion - 0.9903 99.03%
Eye irritation - 0.8993 89.93%
Skin irritation - 0.5758 57.58%
Skin corrosion - 0.9493 94.93%
Ames mutagenesis - 0.8600 86.00%
Human Ether-a-go-go-Related Gene inhibition + 0.7301 73.01%
Micronuclear - 0.8400 84.00%
Hepatotoxicity - 0.8947 89.47%
skin sensitisation - 0.8778 87.78%
Respiratory toxicity - 0.5556 55.56%
Reproductive toxicity + 0.8778 87.78%
Mitochondrial toxicity - 0.7125 71.25%
Nephrotoxicity - 0.9334 93.34%
Acute Oral Toxicity (c) III 0.7136 71.36%
Estrogen receptor binding + 0.7630 76.30%
Androgen receptor binding + 0.7360 73.60%
Thyroid receptor binding + 0.5979 59.79%
Glucocorticoid receptor binding + 0.7909 79.09%
Aromatase binding + 0.6643 66.43%
PPAR gamma + 0.8194 81.94%
Honey bee toxicity - 0.6896 68.96%
Biodegradation - 0.7000 70.00%
Crustacea aquatic toxicity - 0.5650 56.50%
Fish aquatic toxicity + 0.9825 98.25%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 98.47% 91.11%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 97.44% 96.09%
CHEMBL3714130 P46095 G-protein coupled receptor 6 94.31% 97.36%
CHEMBL3137262 O60341 LSD1/CoREST complex 92.89% 97.09%
CHEMBL2581 P07339 Cathepsin D 90.06% 98.95%
CHEMBL335 P18031 Protein-tyrosine phosphatase 1B 89.00% 95.17%
CHEMBL1293249 Q13887 Kruppel-like factor 5 88.68% 86.33%
CHEMBL1806 P11388 DNA topoisomerase II alpha 87.69% 89.00%
CHEMBL4303 P08238 Heat shock protein HSP 90-beta 86.93% 96.77%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 86.54% 94.45%
CHEMBL5255 O00206 Toll-like receptor 4 85.56% 92.50%
CHEMBL1994 P08235 Mineralocorticoid receptor 84.55% 100.00%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 84.10% 95.56%
CHEMBL221 P23219 Cyclooxygenase-1 83.39% 90.17%
CHEMBL5608 Q16288 NT-3 growth factor receptor 81.42% 95.89%
CHEMBL253 P34972 Cannabinoid CB2 receptor 80.79% 97.25%
CHEMBL4187 Q99250 Sodium channel protein type II alpha subunit 80.45% 95.50%

Plants that contains it

Top
Below are displayed all the plants proven (via scientific papers) to contain this compound!
To see more specific details click the taxa you are interested in.
Xerospermum noronhianum

Cross-Links

Top
PubChem 44541444
LOTUS LTS0010464
wikiData Q105281933